Arthur Hayes Bullish on DOGE and Pendle Amid Crypto Slumpby John Darbie 21.06.2024BitMEX's Arthur Hayes sees bullish potential in Dogecoin (DOGE) and Pendle (PENDLE), investing $8.4M in PENDLE amid a crypto market ...
ETH Hovers at $3.5K; Bears Eye $3,000 Target Nextby John Darbie 21.06.2024Ethereum holds steady at $3,500 despite market corrections; bears target $3,000. Key support and resistance levels to watch for future ...
Bitcoin Price Plummets Below $64K Amid Market Turmoilby John Darbie 21.06.2024"Discover why Bitcoin's price is down today: market declines, trader fatigue, and ETF outflows impacting the broader cryptocurrency market."
Quick Money with Crypto in 2024: 6 Proven Methodsby John Darbie 21.06.2024Discover 6 fast ways to make money with crypto in 2024, including cloud mining, affiliate programs, staking, and more. Secure ...
Solana Gains 25% DEX Market Share, Faces New Rivalby John Darbie 21.06.2024"Solana surges to capture 25% of DEX volume amid memecoin boom, driven by low fees and Phantom wallet's rise, challenging ...
Bitcoin to $1 Million? Analysts Predict Eventual Surgeby John Darbie 21.06.2024AllianceBernstein forecasts Bitcoin soaring to $1M by 2033, with key milestones and institutional adoption driving the cryptocurrency's growth.
CFTC Probes Jump Crypto Amid Legal Scrutiny and Turbulenceby John Darbie 21.06.2024CFTC investigates Jump Crypto amid a turbulent crypto landscape; scrutiny over regulatory compliance and past challenges, no comments from either ...
Dogecoin Traders Turn to Shorting Amid Meme Coin Declineby John Darbie 20.06.2024"Dogecoin falls 12%, erasing March gains; meme coin sector sees bearish shift as traders favor stable tokens amid broader market ...
Ethereum’s Price Surge: Whale Activity Sparks Hope, Risks Persistby John Darbie 20.06.2024"Ethereum rebounds to $3,527, buoyed by strong whale activity and breaking key resistance levels, but faces potential market and regulatory ...
ADC Therapeutics Director Azelby Sells Shares Amid Price Target Cutby Mark Eisenberg 20.06.2024Robert Azelby sells $20,215 in ADC Therapeutics shares for tax reasons; holds 53,005 shares. Investors eye insider actions for future ...